INTANGIBLE ASSETS (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets
Accumulated Amortization	$ (252,947)	$ (200,626)
Indefinite-Lived Intangible Assets
Gross Carrying Amount	3,046,368	2,606,598
Net Amount	2,793,421	2,405,972
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,474,061	1,203,987
Net Amount	1,474,061	1,203,987
Multiple Trademarks [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	201,432	185,465
Net Amount	201,432	185,465
Opera Software Patent [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	31,951	31,951
Accumulated Amortization	(7,988)	(6,490)
Net Amount	$ 23,963	$ 25,461
Weighted average remaining amortization period	12 years	12 years 9 months
Development Costs Of Corporate Website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 91,743	$ 91,743
Accumulated Amortization	(91,743)	(91,743)
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,247,181	1,093,452
Accumulated Amortization	(153,216)	(102,393)
Net Amount	$ 1,093,965	$ 991,059
Weighted average remaining amortization period	15 years 3 months	16 years